Sodium oxybate therapy for the treatment of alcohol withdrawal syndrome and the maintenance of alcohol abstinence

Elvira Ventura Spagnolo, Fabrizio Calapai, Michele Navarra, Carmen Mannucci, Gioacchino Calapai, Sebastiano Gangemi, Simona Pichini

Risultato della ricerca: Article

2 Citazioni (Scopus)

Abstract

Gamma-hydroxybutyrate (GHB or sodium oxybate) is both an exogenous and endogenous molecule with neuromodulator properties. In the United States, GHB is an approved drug for the treatment of narcolepsy and narcolepsy with cataplexy in adults. In some European Union countries, sodium oxybate is applied for the treatment of opioid and alcohol withdrawal.
Lingua originaleEnglish
Numero di pagine9
RivistaCurrent Drug Metabolism
Volume19
Stato di pubblicazionePublished - 2017

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Clinical Biochemistry

Cita questo